Recalls and alerts more than 4 years old are automatically archived. While this information can still be accessed in the database, it has not been altered or updated since it was archived. Web pages that are archived on the Web are not subject to the Government of Canada Web Standards. As per the Communications Policy of the Government of Canada, you can request alternate formats by contacting us.

Libidus (September 14, 2006)

Starting date:
September 14, 2006
Posting date:
October 02, 2006
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-2006A197

Reason

Laboratory analysis conducted by Health Canada has determined that samples of Libidus lot# LIB06010 obtained from NorthRegentRx, Winnipeg, Manitoba and a Canadian retailer contain piperidino vardenafil as an undeclared ingredient.

Depth of distribution

Retailers and Individuals in Canada.

Affected products

Libidus

DIN, NPN, DIN-HIM

No market authorization

Dosage form

Capsule

Strength

  • Eurycoma Longifolia (154.0 mg)
  • Flos Carthami (24.5 mg)
  • Rhizoma Cucurmae Longae (49.0 mg)
  • Herba Ginkgo Biloba Extract (49.0 mg)
  • Herba Epimedii (24.5 mg)
  • Herba Cistanches (24.5 mg)
  • Astragalus Membranaceus (24.5 mg)

Lot or serial number

LIB06010, LIB06011

Companies

Recalling Firm
NorthRegentRx
P.O. Box 49082, RPO Garden City
Winnipeg Manitoba
Canada R2V 4G8
Marketing Authorization Holder
Not Applicable